Besterman, Aaron D. http://orcid.org/0000-0002-8671-1203
Jeste, Shafali S. http://orcid.org/0000-0003-2955-6902
Funding for this research was provided by:
national institute of general medical sciences (2T32GM008243‐3)
savant fellowship in neurodevelopmental genetics
Article History
Received: 29 June 2021
Accepted: 23 September 2021
First Online: 5 October 2021
Declarations
:
: Aaron D. Besterman has no conflicts of interest to disclose. Shafali S. Jeste served as a consultant for Roche Pharmaceuticals and on the professional advisory board for the Tuberous Sclerosis Alliance. All drafts of this manuscript were fully written and prepared by the study authors.